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Background: Tombusvirus P19 is a protein encoded by tomato bushy stunt virus and related tombusviruses. Earlier
studies have demonstrated that P19 is an RNA silencing suppressor (RSS) in plant cells. However, it has not been
systematically investigated how P19 suppresses RNA interference in various mammalian cell settings.
Results: We have studied the RSS effect of P19 in mammalian cells, HEK293T, HeLa, and mouse embryonic
fibroblasts. We have individually mutated 18 positively charged residues in P19 and found that 6 of these charged
residues in P19 reduce its ability to suppress RNA interference. In each case, the reduction of silencing of RNA
interference correlated with the reduced ability by these P19 mutants to bind siRNAs (small interfering RNAs).
Conclusions: Our findings characterize a class of RNA-binding proteins that function as RSS moieties. We find a
tight correlation between positively charged residues in P19 accounting for siRNA-binding and their RSS activity.
Because P19’s activity is conserved in plant and animal cells, we conclude that its RSS function unlikely requires cell
type-specific co-factors and likely arises from direct RNA-binding.Background
RNA interference (RNAi) is a mechanism of gene regu-
lation that is conserved in a wide range of organisms,
from plants to animals [1-3]. RNAi is also reported to
function as an antiviral defense against viral infections
[4-9]. To counteract host cell RNAi-mediated immunity,
viruses have evolved a variety of countermeasures, one
of which is to encode RNA silencing suppressor (RSS)
proteins [10-14]. Many RSS proteins have been reported;
they include tomato bushy stunt virus (TBSV) P19 pro-
tein, rice hoja blanca virus NS3 protein, vaccinia virus
E3L, influenza A virus NS1 protein, the Ebola virus VP35
protein, HIV-1 Tat protein, amongst others [5,15-23].
Currently, it is incompletely understood how each of these
RSS proteins works mechanistically.
One of the better characterized RSS is the P19 protein
[13,16,24] encoded by TBSV and related tombusviruses* Correspondence: kjeang@niaid.nih.gov
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reproduction in any medium, provided the or[25]. An association between P19 and siRNAs has been
demonstrated in infected plants [26]. The crystal structure
of P19-siRNA complex reveals that a P19 homodimer
tightly binds a single 21-nucleotide (nt) siRNA duplex in a
positively charged surface cleft, but that this binding is
progressively weaker for a siRNA of 23–26 nt in size and
become even weaker for a 19 nt siRNA [26,27]. Two tryp-
tophan residues (W39 and W42) in P19 act as calipers to
precisely bracket both ends of the siRNA duplex with a
2-nt 3’ overhang. Mutation of these two tryptophan resi-
dues was shown to greatly reduce RNAi suppression in N.
benthamiana plants due to decreased binding of siRNA
[26]. Upon TBSV infection of N. benthamiana and N.
clevelandii, P19 contributes to regulating the manifest-
ation of symptomatic phenotypes, such as apical necrosis
and subsequent death [28,29].
To understand the mechanism of action of RSS pro-
teins, it is important to determine whether cell specific
proteins provide co-factor functions in the suppression
of RNAi activities. Indeed, there is discordant data in the
literature that suggest P19 does [30] or does not [31]This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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variant results between human 293T versus HeLa cells.
Of relevance, several RSS proteins expressed by animal
viruses have been demonstrated to maintain RSS activity
in plants. For example, influenza A virus NS1 protein
suppresses RNA silencing in plant cells by binding
siRNA [32], and the expression of HIV-1 Tat protein in
N. benthamiana restores GFP fluorescence by inhibiting
RNA silencing downstream of the maturation step of
dsRNA duplexes [33]. Here, we have re-examined the
expression of TBSV plant virus P19 RSS protein in ani-
mal cells to determine the requirements for its suppres-
sion of RNA interference. We have assessed the RSS
activity of TBSV P19 employing quantitative luciferase
assays in mammalian HEK293T cells, HeLa cells, and
mouse embryonic fibroblasts (MEFs). In our study, we
have individually mutated eighteen positively charged
amino acid residues and have found six that are involved
in RNA-binding. We have determined a strict correl-
ation between those charged residues needed (not
needed) for RNA-binding and their necessary (unneces-
sary) contribution to the RSS activity of P19.
Results
P19 suppresses shRNA- and siRNA- mediated RNAi
silencing in mammalian cells
To investigate systematically TBSV P19 suppression of
RNAi-silencing in mammalian cells, we first studied itsFigure 1 shRNA-mediated RNAi silencing in HEK293T cells by P19, Ta
plasmids for firefly (Fluc) and Renilla luciferase (Rluc) together with a shRNA
(shGFP, lane 1). As indicated, increasing amounts of expression plasmids fo
also co-transfected into HEK293T cells. Luciferase activities were quantified
on the averages from three independent experiments.activity in HEK293T cells, where its RSS activity, using a
V5-epitope tagged P19 expression vector, was previously
reported as inactive [31]. For this purpose, we co-
transfected HEK293T cells with expression vectors for a
Firefly luciferase (Fluc), a Renilla luciferase (Rluc), and a
shRNA (small hairpin RNA) targeting Firefly luciferase
mRNA (sh-Fluc) [34]. In this context, the expression of
the shRNA, sh-Fluc, is expected to silence the Fluc mRNA
while leaving undisturbed the Rluc mRNA. We also indi-
vidually co-introduced into the transfected cells expres-
sion vectors for FLAG-tagged P19 (referred to hereafter
simply as P19), HIV-1 Tat protein, VP35 Ebola virus pro-
tein, or a CMV-immediate early promoter driven expres-
sion vector that expresses a polypeptide of 45 repeated
arginines (i.e. pCMV-45R). If the latter expression vectors
produce RSS activity, we expect to measure a reduction in
the ability of sh-Fluc to silence Fluc mRNA. After co-
transfecting Fluc+Rluc+sh-Fluc with P19, Tat, VP35 or
pCMV-45R into cells for 20 hours, the Fluc/Rluc ratios
from individual HEK293T samples were determined by
luminometric measurements (Figure 1). We observed that
P19, Tat, VP35 and 45R (Figure 1) all provided dose-
dependent RSS activities in HEK293T cells suppressing
shRNA-mediated gene-silencing. In these assays, the RSS
activity of P19 was slightly stronger than that shown by
Tat, VP35 or the 45R peptide.
Because shRNA-mediated RNAi requires a Dicer pro-
cessing step [35-37] while siRNA-mediated RNAi doest, VP35 or 45R. HEK293T cells were transfected with expression
that targets Fluc (sh-Fluc, lanes 2–17) or a control irrelevant shRNA
r GFP, FLAG-tagged P19, Tat, VP35 or 45R (45 repeated arginines) were
at 20 hours post transfection, and Fluc/Rluc ratios are graphed based
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achieved if we employed a siRNA (si-Fluc)-targeting
Firefly luciferase mRNA in place of sh-Fluc. We thus
compared the ability of P19, Tat, VP35 and 45R to sup-
press si-Fluc silencing of Fluc-mRNA. Figure 2 shows
that P19, Tat, VP35, or 45R showed similar dose-
dependent effects on si-Fluc (Figure 2) as they did on
sh-Fluc (Figure 1).
Point mutation of positively charged residues in P19
affects its suppression of RNA interference
Sequence analysis of TBSV P19 shows that there are 18
positively charged residues of either lysine or arginine
that are considered generally important for binding nu-
cleic acids. We individually point mutated all 18 posi-
tively charged residues to examine the impact of these
changes on P19’s RSS activity. Western blotting of the
expression of these point mutants demonstrated that
none of the point changes significantly affected protein
stability (Figure 3). In assays for RSS activity in
HEK293T cells, we compared in parallel the wild type
P19 and the 18 point mutants (Figure 4, 5). Amongst
the 18 mutants that were tested, only 6 mutants (R43A,
K60A, K71A, R72A, R75A and R85A) exhibited a loss of
their RSS capability to suppress sh-Fluc-mediated RNAi
silencing (Figure 4). Similar results were seen in RSS
assays for the suppression of si-Fluc (Figure 5). Taken
together, the results support that these 6 residues are of
predominant importance to the RSS activity of P19 in
mammalian cells.Figure 2 Inibition of siRNA-mediated RNAi silencing in HEK293T cells
expression plasmids for firefly (Fluc) and Renilla luciferase (Rluc) together w
siRNA (lane 1). As indicated, increasing doses of expression plasmids for GF
transfected into HEK293T cells. Luciferase activities were quantified at 20 ho
averages from three independent experiments.P19 residues contributory to RSS are critical for RNA-
binding
Above, we found that individual changes in 6 positively
charged residues in P19 produced a loss of RSS activity.
One explanation for this loss of function could be that the
amino acid changes affected the RNA-binding activity of
P19. To address this possibility, RNA-binding native gel
shift assays were carried out using si-Fluc RNA and puri-
fied P19 proteins. In titrating increasing amount of P19 in
the presence of an excess of siRNA, we first established
optimal binding condition of wild type P19 for siRNA
(Figure 6A). Next, we checked the binding of P19 or its
mutants to si-Fluc siRNA. Indeed, while wild type P19
and other mutants that did not affect RSS (e.g. R3A,
R11G, R18A, K31A, K67A, R78A, R101A, R115G, R117G,
R139A, R141A, R158A) bound si-Fluc siRNA, each of the
six mutants (R43A, K60A, K71A, R72R, R75A, R85A) that
lost RSS function failed to bind si-Fluc siRNA (Figure 6B).
Collectively, these results support the interpretation that
the RNA-binding activity of P19 in mammalian cells is the
primary determinant of its RSS activity.
PACT is not required for P19 suppression of sh-/si-RNA-
mediated RNAi silencing in MEF cells
Previously, it was reported that untagged P19 exhibited
RSS activity in HeLa cells [30] while epitope-tagged P19
had no RSS activity in 293T cells [31] Amongst various
interpretations, one possibility was that perhaps P19’s
RSS activity requires cell type-specific co-factor(s) that is
present in HeLa, but not 293T cells. While our aboveby P19, Tat, VP35 or 45R. HEK293T cells were transfected with
ith a siRNA that targets Fluc (si-Fluc, lanes 2–17) or a control scramble
P, FLAG-tagged P19, Tat, VP35 or 45R (45 repeated arginines) were also
urs post transfection, and Fluc/Rluc ratios are graphed based on the
Figure 3 Expression of P19 and mutants in HEK293T cells. Wild type P19 or the indicated mutants were loaded in equal amounts and
Western blotted using P19 specific polyclonal serum.
Figure 4 Suppression of shRNA-mediated RNAi-silencing by P19 or P19 mutants in HEK293T cells. HEK293T cells were transfected with
expression plasmids for firefly (Fluc) and Renilla luciferase (Rluc) together with a shRNA that targets Fluc (sh-Fluc) or a control irrelevant shRNA
(shGFP, lane 1). Increasing doses of the indicated expression plasmids for FLAG-P19 or FLAG-P19 mutants were also transfected into HEK293T
cells. Luciferase activities were quantified at 20 h post transfection. Fluc/Rluc ratios are graphed based on the averages from four independent
experiments. Please note that in the top and bottom graphs the identical values from wild type P19 are presented twice simply for the purpose
of easier comparison with the values from the respectively graphed P19 mutants.
Liu et al. Cell & Bioscience 2012, 2:41 Page 4 of 10
http://www.cellandbioscience.com/content/2/1/41
Figure 5 Suppression of siRNA-mediated RNAi-silencing by P19 or P19 mutants in HEK293T cells. HEK293T cells were transfected with
expression plasmids for firefly (Fluc) and Renilla luciferase (Rluc) together with a siRNA that targets Fluc (si-Fluc) or a control irrelevant siRNA
(scrambled siRNA, lane 1). Increasing doses of the indicated expression plasmids for FLAG-P19 or FLAG-P19 mutants were also transfected into
HEK293T cells. Luciferase activities were quantified at 20 h post transfection. Fluc/Rluc ratios are graphed based on the averages from four
independent experiments. Please note that in the top and bottom graphs the identical values from wild type P19 are presented twice simply for
the purpose of easier comparison with the values from the respectively graphed P19 mutants.
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ectly investigate cell type-specific influences on P19’s
RSS, we extended our assays to primary mouse embry-
onic fibroblasts (MEFs). We tested P19’s RSS activity in
wild type MEFs and also in MEFs that are knocked out
for the PACT gene (i.e. PACT−/−) (Figure 7). We investi-
gated the latter cells because the PACT protein has been
reported to be an important component of the mamma-
lian RNAi machinery [38,39]. In both wild type and
PACT−/− MEFs, P19 was effective in suppressing both
sh- and si- RNA-mediated silencing of Fluc (Figure 7).
These findings suggested that there is no cell type or
species-specific differences between 293T cells and pri-
mary MEFs for P19’s RSS function and that this P19-
activity does not require PACT as a co-factor.The PACT-related protein TRBP [40] is another cellu-
lar RNA-binding proteins that has been reported to be
important for the loading of siRNAs into the RNA-
induced silencing complex (RISC) for functional RNAi
activity in mammalian cells [35,38,41-43]. We next
checked if loss of TRBP would affect P19’s RSS activity.
To address this requirement, we conducted sh-/si-Fluc
mediated silencing of Fluc mRNA in wild type MEF and
TRBP knock out MEF (i.e. TRBP−/−) and tested the
functionality of P19’s RSS in these contexts (Figure 8).
Although others had reported a functional redundancy
and general equivalence between PACT and TRBP for
mammalian RNAi function [44,45], in our assays, we
found that sh-/si-Fluc-mediated silencing was very poor
and was essentially non-functional in TRBP−/− MEFs
Figure 6 In vitro RNA-binding by P19 and P19 mutants. Gel shift assays were performed for FLAG-P19 and mutated FLAG-P19 proteins. A)
Increasing amount of FLAG-P19 was incubated for 30 minutes with 0.2 μM si-Fluc at 25°C. The amount of FLAG-P19 were quantified by Western
blot analysis using anti-FLAG antibody. B) Equal amounts of purified FLAG-P19 or mutants were incubated for 30 minutes with 0.2 μM si-Fluc at
25°C. RNA was separated on 2% TBE-agarose gel and visualized by staining with ethidium bromide. The protein expression of FLAG-P19 and
mutants were shown using Western blot analysis.
Figure 7 P19 suppression of sh-RNA-mediated RNAi silencing does not require PACT. WT and PACT−/− MEFs were transfected with
expression plasmids for firefly (Fluc) and Renilla luciferase (Rluc) together with sh-/si-RNAs that target Fluc (sh-/si-Fluc) or a control irrelevant
shRNA (shGFP, lane 1, left panel) or scramble siRNA (lane 1, right panel). Increasing doses of expression plasmids for FLAG-P19 were also
transfected into MEF cells. The results are averages from four independent experiments.
Liu et al. Cell & Bioscience 2012, 2:41 Page 6 of 10
http://www.cellandbioscience.com/content/2/1/41
Figure 8 TRBP is required for optimal sh-/si-RNA-mediated RNAi silencing. WT and TRBP−/− MEFs were transfected with expression plasmids
for firefly (Fluc) and Renilla luciferase (Rluc) together with sh- /si-RNAs that target Fluc (sh-/si-Fluc) or a control irrelevant shRNA (shGFP, lane 1,
left panel) or scrambled siRNA (lane 1, right panel). Increasing doses of expression plasmids for FLAG-P19 were also transfected into MEF cells.
The results are averages from four independent experiments.
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PACT−/− MEFs . Thus in the context of our MEFs, our
findings indicate a more important role of TRBP in
siRNA loading into RISC that is not equivalently substi-
tuted by PACT [44,45]. Because si- and sh- RNA-
mediated silencing of Fluc worked poorly in these
TRBP-null MEFs, P19’s RSS activity in TRBP−/− MEFs
could not be determined under these conditions. How-
ever, when higher siRNA concentrations were used in
TRBP−/− MEFs, we could achieve RNAi-mediated silen-
cing of Fluc mRNA that was suppressed by P19, suggest-
ing that TRBP is also not a necessary co-factor for P19’s
RSS in MEFs (data not shown).
Discussion/conclusion
Here, we report that the RSS activity of FLAG-tagged
TBSV P19 is conserved in human HEK293T cells and
mouse embryonic fibroblasts (MEF). We also found that
FLAG-P19 has similar RSS activity in HeLa cells
(Additional file 1: Figure S1) as in HEK293T cells. Our
work revisits earlier reports that untagged P19 exhibited
RSS activity in HeLa cells [30] while epitope-tagged P19
showed little to no RSS activity in 293T cells [31], sug-
gesting that neither epitope-tagging nor cell type-specific
factors influence inherent P19 RSS activity in mamma-
lian cells. We should, however, caution that our assay
approaches are similar to, but not identical with, the
previous studies; hence, we cannot exclude that small
non-identical experimental details may account for the
dissimilar findings.
In trying to characterize P19’s RSS activity in animal
cells, we point mutated 18 positively charged lysine or
arginine amino acids to neutral amino acid counterparts.
In these analyses, we discovered 6 positively chargedresidues that are important for P19-mediated RSS effect.
Mutation of these residues also abrogated the ability of
the respective protein to bind siRNA. Our mutagenesis
results on P19 in animal cells can be compared to paral-
lel point mutation studies of P19 in plant cells. Thus,
Chu et al. had shown that mutations upstream from
residue K71 or downstream from residue R85 did not
noticeably affect the ability of TBSV to systematically in-
vade spinach plants [25]. Mutation of R72, R75 or R85
displayed a reduced lethal necrosis phenotype in three
different plants (N. benthamiana, N. clevelandii and
spinach) [25], and the mutation of R43 was shown to de-
crease the stability of interaction between P19 (R43) pro-
tein and siRNA in N. benthamiana [46]. Crystal
structure of P19 revealed that K71 and R115 form direct
contacts with phosphate groups in the siRNA [27].
Viewed in the above context, our results in mammalian
cells show that K71 is important for RSS activity of P19,
but mutation of R115 did not affect this activity.
Previously, mutation of K60 in infected plants showed
necrotic lower leaves, but not systemic collapse [25]; and
our results also showed that mutation of K60A greatly
reduced the RSS effect and RNA binding activity of P19.
Therefore, for the most part, those positively charged
residues that contribute to RSS activity of P19 maintain
similar functional roles in mammalian and plant cells,
further supporting the notion that the P19 RSS effect in
plants and animals arises from co-factor independent
direct RNA-binding.
An unexpected observation from our work is that sh-/
si-Fluc-mediated silencing was more efficient in PACT−/−
MEFs (Figure 7) than TRBP−/− MEFs (Figure 8). These
results suggest a role for TRBP in siRNA loading into
RISC that may not be equivalently substituted by PACT.
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complex with Dicer and Ago2 and contribute to the pro-
cessing of miRNA and shRNA, increasingly nuanced stud-
ies had indicated that TRBP appears to have a more
critical role than PACT [44,45] in the cellular RNAi
process. Indeed, a recent study showed that TRBP, but not
PACT, can directly influence the specificity of Dicer cleav-
age of pre-miRNA [47]. Relevant to P19, our results
suggest that neither PACT nor TRBP plays an essential
co-factor role for P19’s RSS activity.
Our results here reinforce the earlier notion that many
RNA-binding proteins can function as RNAi-suppressors
[5,19,20,48,49] . Indeed, we have previously shown [34],
and reaffirmed in Figure 1, that simple RNA-binding
polypeptides like poly-arginine can exhibit RNAi-
suppressing activity. Viral RNA-binding proteins like
HIV-1 Tat and HTLV-1 Rex have evolved to serve virus-
specific roles, but consistent with our current findings
on P19, they also show RSS activity [20,50], suggesting
that they participate in aspects of virus-cellular RNAi en-
gagement [6]. RNAi activity contributes wide-ranging and
diverse roles in cellular proliferation, gene regulation, de-
velopment, metabolism, immune response, infection, and
pathogenesis [51-54]. Physiologically, a reasonable notion
is that organisms should have evolved biological means
that either enhance or repress RNAi activities. We
hypothesize that many cellular RNA-binding proteins
[55] may possess suppressive RSS activities while others
like TRBP may positively enhance RNAi function.
Recently, a computational strategy was used to screen
for small molecules with the potential to inhibit miRNA
functions [56]. Going forward, further work on the dis-
covery of small molecule inhibitors may help us develop
tools to understand better how cellular RNA-binding
proteins influence RNAi functions in cells.Methods
Plasmids and reagents
The expression vectors for Fluc and Rluc are the
pGL3-plasmid (Promega, Madison, WI) and the pRL-
TK plasmid (Promega), respectively. pRS-shLuc (sh-Fluc),
pRS-shGFP and pRS control plasmids were purchased
from Origene. pCMVp19FL9 (FLAG-tagged), mam-
malian expression vector for P19, was a gift from Dr.
Kathleen Boris-Lawrie (Ohio State University, USA).
The plasmid of pcDNA3.1-VP35 was a gift from Dr. Stuart
Nichols (Center for Disease Control, USA). The plasmids
of pcDNA-TRBP and pCMV-45R (expression vector
for 45 repeated arginines) were constructed in our
laboratory. TBSV P19 rabbit polyclonal antibody was a
kind gift from Dr. Herman B. Scholthof (Texas AM
University, USA). siRNA to Firefly luciferase was from
Invitrogen.Cell culture and transfection
HEK293T cells, wild type MEF and knockout MEF cells
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS), 2 mM/l L-glutamine and antibiotics in 5% CO2 at
37°C. Cells were transfected with 50 ng Fluc, 50 ng
sh-Fluc (or sh-GFP), 5 ng Rluc, together with increasing
dose (25 ng, 50 ng and 100 ng) of RSS proteins or P19
mutants. 25 pM si-Fluc siRNA were used to transfect
both HEK293T cells and MEFs. PACT−/− MEF cells are
gifts from Dr. Ganes C. Sen (Cleveland Clinic, USA)
[57,58]. TRBP−/− mice are gifts from Dr. Robert E. Braun
(Jackson Laboratory, USA) [59]. TRBP−/− MEF cells were
generated in our laboratory.Luciferase assay
Luciferase activity was quantified using the Dual-Glo
Luciferase assay system (Promega) according to the
manufacturer’s protocol.Western blot
The cells were washed with PBS twice and then lysed in
lysis buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl,
5 mM EDTA, 1% Triton X-100, 0.1% SDS) supplemented
with protease inhibitor cocktail (Roche). The lysates
were resolved by 12% SDS-PAGE and transferred to
polyvinylidene fluoride membranes (Millipore). The
membrane was incubated with primary antibodies,
followed by alkaline phosphatase-conjugated secondary
antibodies (Sigma-Aldrich). Signals were visualized
using chemiluminescence following the manufacturer’s
protocol (Chemicon).Immunoprecipitation
HEK293Tcells were lysed with RIPA buffer for 20 minutes
at 4°C. Lysates were clarified at 12,000 rpm for 10 minutes
at 4°C, then incubated with anti-Flag beads (Sigma), and
then rotated slowly at 4°C overnight. The antibody-bound
complexes were washed three times and eluted by resus-
pending the beads with Flag-polypeptides. The super-
natant was centrifuged and concentrated.Gel shift assay
Gel shift assay was performed using purified P19 or its
mutants with 0.2 μM siRNAs in buffer containing 50 mM
Tris–HCl (pH 7.4) and 100 mM NaCl. After incubation
for 30 minutes at 25°C, the reaction mixtures were sepa-
rated on 2% Tris-Borate-EDTA (TBE)-agarose gels. The
RNA was visualized by staining with ethidium bromide at
1 μg/ml.
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Additional file 1: Figure S1. sh-/si-RNA-mediated RNAi silencing in
HeLa cells by P19, Tat, VP35 or 45R. A) Inhibition of shRNA-mediated
RNAi silencing in HeLa cells by FLAG-P19, Tat, VP35 or 45R. HeLa cells
were transfected with expression plasmids for firefly (Fluc) and Renilla
luciferase (Rluc) together with a shRNA that targets Fluc (sh-Fluc, lanes
2–17) or a control irrelevant shRNA (shGFP, lane 1). As indicated,
increasing amounts of expression plasmids for GFP, FLAG-P19, Tat, VP35
or 45R (45 repeated arginines) were also co-transfected into HeLa cells.
B) Inhibition of siRNA-mediated RNAi silencing in HeLa cells by FLAG-P19,
Tat, VP35 or 45R. HeLa cells were transfected with expression plasmids for
firefly (Fluc) and Renilla luciferase (Rluc) together with a siRNA that
targets Fluc (si-Fluc, lanes 2–17) or a control scrambled siRNA (lane 1). As
indicated, increasing doses of expression plasmids for GFP, FLAG-P19, Tat,
VP35 or 45R (45 repeated arginines) were also transfected into HeLa cells.
Luciferase activities were quantified at 20 hours post transfection, and
Fluc/Rluc ratios are graphed based on the averages from three
independent experiments.
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